In the first half of the fiscal year ending March 2025, for the period ended September 30, 2024, Fujifilm Holdings Corporation recorded revenue of ¥1,514.7bn (£7.62bn).
Operating income also benefited from revenue growth and the exchange rate impact, amounting to ¥135.6bn, increasing by 8% year-on-year.
Net income attributable to Fujifilm Holdings decreased by 2.9% year-on-year to ¥110.3bn.
In light of the strong performance of the Electronics and Imaging segment and the exchange rate, full-year consolidated forecast for the fiscal year ending March 2025 remains unchanged from the previous forecast with some adjustments between the businesses, at revenue of ¥3,150bn, operating income of ¥315bn, and net income attributable to Fujifilm Holdings of ¥250bn, aiming to achieve record highs.
By sector, in the manufacturer’s Business Innovation wing, overall revenue decreased by 0.7% year-on-year to ¥287.7bn, while operating income dropped by 29.3% year-on-year to ¥10.8bn, due to the impact of a revenue reduction and the damage caused by a typhoon to a factory in Vietnam, among other factors.
In the Graphic Communications business, Fujifilm said revenue increased due to the increased sales of printing plates for the US – despite the ongoing import duties row there – as well as digital presses for Europe and the US, and inkjet heads for the ceramic and commercial printing markets.
In the Business Solutions business, revenue increased – mainly due to higher sales of “solutions related to digital transformation” (DX).
In the Office Solutions business, revenue decreased due to inventory adjustments by major European and American OEM customers of multifunction devices and the termination of sales of low-profit small printers for Europe and America, despite an increase in exports of consumables to Europe and America following the momentum generated in the first quarter.
Among its other businesses, Healthcare revenue increased by 0.6% year-on-year to ¥242.9bn, primarily driven by the stronger performances from Medical Systems and LS Solutions businesses.
However, operating income decreased 40.3% year-on-year to ¥18.8bn mainly attributed to expenses incurred for enhancing the system to support the expansion of commercial manufacturing at the Bio CDMO business site in Texas, as well as the repercussions of the one-time income recorded in the prior period for LS Solutions.
In Electronics, revenue increased by 31.4% year-on-year to ¥108.7bn and operating income increased 94.2% year-on-year to ¥19.5bn.
Finally, in Imaging, strong sales of instant photo systems and digital cameras boosted revenue by 11% year-on-year to ¥126.5bn and operating income by 29.2% year-on-year to ¥33.7bn.
“We have continued strong performance in the Electronics and Imaging segments, resulting in unprecedented sales and operating profit in the first half of fiscal year 2024,” said Teiichi Goto, president and CEO, representative director at Fujifilm Holdings Corporation.
“We are maintaining our performance forecast to achieve record-high sales and profitability for the fiscal year ending March 2025. We are actively investing in facilities in growth areas such as Semiconductor Materials and Bio CDMO, demonstrating our confidence in expanding our business.”
Fujifilm’s share price was down by 3.35% on yesterday’s close at the time of writing today at ¥3,515 (52-week high: ¥3,999; low: ¥2,744).
